Stereotactic body radiotherapy plus cetuximab for previously irradiated un-resectable head and neck cancer

BACKGROUND: The aim of the study was to explore the treatment outcomes and prognostic factors for patients with previously irradiated but unresectable recurrent head and neck squamous cell carcinoma (rHNSCC) treated by stereotactic body radiotherapy (SBRT) plus cetuximab at a single institute in Tai...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Tai-Lin, Chuang, Hui-Ching, Tsai, Ming-Hsien, Chien, Chih-Yen, Su, Yan-Ye, Lin, Yu-Tsai, Yang, Chao-Hui, Lai, Chi-Chih, Li, Shau-Hsuan, Fang, Fu-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chang Gung University 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661507/
https://www.ncbi.nlm.nih.gov/pubmed/34749016
http://dx.doi.org/10.1016/j.bj.2021.10.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661507/
https://www.ncbi.nlm.nih.gov/pubmed/34749016
http://dx.doi.org/10.1016/j.bj.2021.10.013

Ejemplares similares